#United States #Chicago #NYU Langone #Cardiovascular Research #AHA 2026

New Insights into Cardiovascular Health from NYU Langone Heart

The American Heart Association (AHA) Scientific Sessions 2026, held in Chicago from November 6 to 9, showcased the cutting-edge cardiovascular research by cardiologists and researchers from the Leon H. Charney Division of Cardiology at NYU Langone Health. This year’s event included a diverse array of studies focusing on long-term treatment strategies, the implications of indoor air quality on health, and innovative digital health tools aimed at enhancing heart failure care.

Dr. Sunil Rao, director of the division, emphasized the breadth of research presented, highlighting its significance in enhancing patient outcomes through a combination of clinical research and technological advancements. Four noteworthy NYU Langone studies were featured prominently in the sessions categorized as Late-Breaking Science and Featured Science, which is a testament to the institution's leadership in this critical field.

Key Research Highlights

1. ### Long-Term Survival in Coronary Artery Disease
The ISCHEMIA-EXTEND study, an international effort, analyzes outcomes among patients with stable coronary artery disease who underwent different treatment strategies. Comparing an initial approach involving invasive procedures alongside medication and lifestyle adjustments against a conservative medical management-only approach, the findings aim to clarify the long-term benefits and risks of each option. Dr. Judith Hochman, chair of the study, underscores the importance of addressing the unique needs of patients facing stable coronary artery disease in contrast to those experiencing acute heart episodes.

2. ### Advanced Kidney Disease and Cardiac Health
Another crucial study, ISCHEMIA-CKD EXTEND, delves into the survival outcomes for patients with coronary artery disease and advanced chronic kidney disease. By examining a cohort of 777 participants through varied treatment protocols, this research endeavors to evaluate strategies to effectively manage both conditions, as this population has historically been underrepresented in cardiovascular research.

3. ### Clean Air and Metabolic Health
Researchers conducted a randomized double-blind study to assess whether HEPA air filters can positively influence blood sugar levels in adults with prediabetes. Over 150 individuals from New York City participated in the study, indicating the often-overlooked connection between indoor air quality and cardiovascular health. Dr. Sharine Wittkopp emphasized the potential that such practical interventions have in supporting better blood sugar management, thereby affecting overall cardiovascular health.

4. ### Digital Alerts for Heart Failure Management
The BETTER CARE-HF multi-center study showcases advancements in electronic health record prompts that assist providers in prescribing essential medications for heart failure patients. This research builds upon previous findings at NYU Langone, highlighting the need for improved treatment adherence across different health systems to enhance patient outcomes.

Additional Findings and Discussions

In addition to the featured studies, several other research initiatives were presented, including:

• - Hypertension Identification through Dental Visits: Focusing on young adults, this research suggests that routine dental check-ups could serve as critical opportunities for early identification of hypertension, allowing for timely intervention.
• - Diagnosis Innovations for MINOCA: Presentations explored methods to improve the identification and treatment of myocardial infarction with non-obstructive coronary arteries, which poses diagnostic challenges for clinicians.
• - The Role of Inflammation in Cardiovascular Treatments: Dr. Jeffrey Berger will present a session addressing the intersection of inflammation and cardiovascular disease, aiming to guide future therapeutic strategies.

NYU Langone Heart consistently ranks as a leader in cardiovascular care, being recognized as the number one institution nationally for cardiology and heart surgery by U.S. News & World Report. With this prestigious reputation, the findings demonstrated at AHA 2026 signify a commitment to translating research into practice, aiming for better health outcomes and innovative treatments for patients at risk of or afflicted by cardiovascular disease.

Through continuous research and development, NYU Langone is not just expanding the horizons of cardiovascular medicine but also paving new paths for patient-centered treatment strategies, thereby influencing the future of cardiac care.